typhoid vaccine


Also found in: Dictionary, Thesaurus, Medical.

typhoid vaccine

[′tī‚fȯid vak′sēn]
(immunology)
A type of killed vaccine used for active immunity production; made from killed typhoid bacillus (Salmonella typhi).
Mentioned in ?
References in periodicals archive ?
Before our study, the most reliable existing estimates of the typhoid fever incidence rates in Egypt were established during typhoid vaccine studies conducted more than two decades earlier.
The study showed that delivering the low-cost Vi typhoid vaccine is logistically and programmatically possible.
There's a lot of activity now in this area, trying to make more specific mutations [in Salmonella] both to improve the current typhoid vaccine and to use as a Trojan horse to carry other antigens," says Spriggs of NIAID.
Phase II study represents an important milestone in the clinical development of our oral typhoid vaccine candidate," said Daniel Abdun-Nabi, president and chief operating officer of Emergent BioSolutions.
NYSE: EBS) announced today that the final analysis from a recently completed, randomized, placebo-controlled, blinded Phase II clinical study reaffirmed that its single-dose, drinkable typhoid vaccine candidate was highly immunogenic and well-tolerated with an acceptable safety profile in the population studied.
Contract notice: Acquisition of 2,807 doses of tetravalent meningococcal vaccine and 4,320 doses of typhoid vaccine, designed to meet the needs of the logistics support unit health.
The company also anticipates continued investment in its advanced product development pipeline, including an anthrax IG therapeutic, hepatitis B therapeutic and typhoid vaccine, among others.
Emergent BioSolutions' product portfolio includes a drinkable Typhoid vaccine candidate, a Hepatitis B therapeutic vaccine candidate, Group B streptococcus vaccine candidate, a Chlamydia vaccine candidate, among others.
4 - Supply typhoid vaccine with international non Typhoid polysaccharide vaccine.
4 - Delivery typhoid vaccine with international non Typhoid polysaccharide vaccine.
NYSE:EBS) announced today that preliminary results from a recently completed, randomized, placebo-controlled Phase II clinical study demonstrated that its single-dose, drinkable typhoid vaccine candidate achieved the study endpoints for safety and immunogenicity.
A new typhoid vaccine is introduced by the Bharat Biotech International Ltd.